Brokers Set Expectations for Innate Pharma FY2030 Earnings

Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Free Report) - Equities researchers at HC Wainwright issued their FY2030 EPS estimates for Innate Pharma in a research report issued on Tuesday, April 7th. HC Wainwright analyst S. Ramakanth expects that the company will post earnings of $0.42 per shar